Document Detail


Can hybrid FDG-PET/CT detect subclinical lymph node metastasis of esophageal cancer appropriately and contribute to radiation treatment planning? A comparison of image-based and pathological findings.
MedLine Citation:
PMID:  19856050     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: We aimed to determine the appropriateness of adding 18F-fluorodeoxyglucose (FDG)-positronemission tomography (PET) to computed tomography (CT) and other pre-existing diagnostic imaging modalities for detecting subclinical lymph node metastasis of esophageal cancer, by comparing images from these modalities with the results of histopathological analysis.
METHODS: Twenty patients who received radical surgery for squamous cell carcinoma of the esophagus were examined by PET-CT, and endoscopic ultrasound (EUS) examination before surgery. Based on these diagnostic modalities, the clinical target volume (CTV) was set as the gross tumor volume (GTV) plus a 1-cm margin. Histopathological diagnosis was performed in all patients immediately after resection.
RESULTS: Fifty-three (3.0%) of 1764 nodes in the 20 patients were histopathologically positive for cancer cells. The CTV was not adequate to cover these histopathologically detected positive lymph nodes in 8 of 20 patients on CT, 5 of 20 on CT+EUS, 7 of 20 on PET-CT, and 5 of 20 on PET-CT+EUS.
CONCLUSION: The detection rate of subclinical lymph node metastasis did not improve with the use of PET-CT, for either the cervical and supraclavicular, mediastinal, or abdominal regions. It is not recommended to use FDG-PET or PET-CT alone as a diagnostic tool to determine CTV if pathologically involved lymphatic regions are to be included in the CTV in the treatment protocol. The accuracy of PET-CT must be further improved in order to better detect positive nodes and improve the definition of the CTV.
Authors:
Shinichi Shimizu; Masao Hosokawa; Kazuo Itoh; Masahiro Fujita; Hiroaki Takahashi; Hiroki Shirato
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2009-10-25
Journal Detail:
Title:  International journal of clinical oncology / Japan Society of Clinical Oncology     Volume:  14     ISSN:  1437-7772     ISO Abbreviation:  Int. J. Clin. Oncol.     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2009-10-26     Completed Date:  2010-01-07     Revised Date:  2011-09-13    
Medline Journal Info:
Nlm Unique ID:  9616295     Medline TA:  Int J Clin Oncol     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  421-5     Citation Subset:  IM    
Affiliation:
Department of Radiology, Hokkaido University, Graduate School of Medicine, Kita-Ku, Sapporo, Japan. sshimizu-rad@umin.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Carcinoma, Squamous Cell / diagnosis*,  radiotherapy,  secondary,  surgery
Endosonography
Esophageal Neoplasms / diagnosis*,  radiotherapy,  secondary,  surgery
Esophagectomy
Female
Fluorodeoxyglucose F18 / diagnostic use*
Humans
Lymph Nodes / radiography*,  radionuclide imaging*,  ultrasonography
Lymphatic Metastasis
Male
Middle Aged
Patient Selection
Positron-Emission Tomography*
Predictive Value of Tests
Radiopharmaceuticals / diagnostic use*
Radiotherapy Planning, Computer-Assisted
Sensitivity and Specificity
Tomography, X-Ray Computed*
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Current therapeutic strategies for anal squamous cell carcinoma in Japan.
Next Document:  High-frequency 30-MHz sonography in preoperative assessment of tumor thickness of primary melanoma: ...